BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Flem-Karlsen K, Fodstad Ø, Nunes-Xavier CE. B7-H3 Immune Checkpoint Protein in Human Cancer. Curr Med Chem 2020;27:4062-86. [PMID: 31099317 DOI: 10.2174/0929867326666190517115515] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Melaiu O, Lucarini V, Giovannoni R, Fruci D, Gemignani F. News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors. Semin Cancer Biol 2020:S1044-579X(20)30156-5. [PMID: 32659257 DOI: 10.1016/j.semcancer.2020.07.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
2 Lin Z, Pang K, Li H, Zhang X, Wan J, Zheng T, Liu T, Peng W. Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma. Front Cell Dev Biol 2021;9:709241. [PMID: 34631703 DOI: 10.3389/fcell.2021.709241] [Reference Citation Analysis]
3 Liao C, An J, Tan Z, Xu F, Liu J, Wang Q. Changes in Protein Glycosylation in Head and Neck Squamous Cell Carcinoma. J Cancer 2021;12:1455-66. [PMID: 33531990 DOI: 10.7150/jca.51604] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Nunes-Xavier CE, Kildal W, Kleppe A, Danielsen HE, Waehre H, Llarena R, Maelandsmo GM, Fodstad Ø, Pulido R, López JI. Immune checkpoint B7-H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer. Prostate 2021;81:838-48. [PMID: 34125445 DOI: 10.1002/pros.24180] [Reference Citation Analysis]
5 Yao HP, Zhao H, Hudson R, Tong XM, Wang MH. Duocarmycin-based antibody-drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: Pharmaceutical strategy and clinical progress. Drug Discov Today 2021;26:1857-74. [PMID: 34224904 DOI: 10.1016/j.drudis.2021.06.012] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Liu X, Zhelev D, Adams C, Chen C, Mellors JW, Dimitrov DS. Effective killing of cells expressing CD276 (B7-H3) by a bispecific T cell engager based on a new fully human antibody. Transl Oncol 2021;14:101232. [PMID: 34601396 DOI: 10.1016/j.tranon.2021.101232] [Reference Citation Analysis]
7 Emaldi M, Nunes-Xavier CE. B7-H4 Immune Checkpoint Protein Affects Viability and Targeted Therapy of Renal Cancer Cells. Cells 2022;11:1448. [PMID: 35563753 DOI: 10.3390/cells11091448] [Reference Citation Analysis]
8 Désage AL, Karpathiou G, Peoc'h M, Froudarakis ME. The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review. Cancers (Basel) 2021;13:3205. [PMID: 34206956 DOI: 10.3390/cancers13133205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cocco C, Morandi F, Airoldi I. Immune Checkpoints in Pediatric Solid Tumors: Targetable Pathways for Advanced Therapeutic Purposes. Cells 2021;10:927. [PMID: 33920505 DOI: 10.3390/cells10040927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Grote S, Ureña-Bailén G, Chan KC, Baden C, Mezger M, Handgretinger R, Schleicher S. In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment. Cells 2021;10:1020. [PMID: 33925968 DOI: 10.3390/cells10051020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yang S, Cao B, Zhou G, Zhu L, Wang L, Zhang L, Kwok HF, Zhang Z, Zhao Q. Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer. Front Pharmacol 2020;11:1089. [PMID: 32848731 DOI: 10.3389/fphar.2020.01089] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
12 Huang L, Zhou Y, Sun Q, Cao L, Zhang X. Evaluation of the role of soluble B7-H3 in association with membrane B7-H3 expression in gastric adenocarcinoma. Cancer Biomark 2021. [PMID: 34459388 DOI: 10.3233/CBM-210178] [Reference Citation Analysis]
13 Liu S, Liang J, Liu Z, Zhang C, Wang Y, Watson AH, Zhou C, Zhang F, Wu K, Zhang F, Lu Y, Wang X. The Role of CD276 in Cancers. Front Oncol 2021;11:654684. [PMID: 33842369 DOI: 10.3389/fonc.2021.654684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wang MY, Qi B, Wang F, Lin ZR, Li MY, Yin WJ, Zhu YY, He L, Yu Y, Yang F, Liu JQ, Chen DP. PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma. Oncogenesis 2021;10:9. [PMID: 33431797 DOI: 10.1038/s41389-020-00293-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Niu Y, Huang Y, Dong A, Sun Y. Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 Possesses Prognostic Significance and Promotes Progression of Papillary Thyroid Cancer. IJGM 2022;Volume 15:1509-16. [DOI: 10.2147/ijgm.s338564] [Reference Citation Analysis]
16 Zhang W, Qiu Y, Xie X, Fu Y, Wang L, Cai Z. B7 Family Members in Lymphoma: Promising Novel Targets for Tumor Immunotherapy? Front Oncol 2021;11:647526. [PMID: 33869045 DOI: 10.3389/fonc.2021.647526] [Reference Citation Analysis]
17 Ding M, Liao H, Zhou N, Yang Y, Guan S, Chen L. B7-H3-Induced Signaling in Lung Adenocarcinoma Cell Lines with Divergent Epidermal Growth Factor Receptor Mutation Patterns. Biomed Res Int 2020;2020:8824805. [PMID: 33426073 DOI: 10.1155/2020/8824805] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Meng F, Chen Y, Yang M, Zhang H, Wang W. Concomitant inhibition of B7-H3 and PD-L1 expression by a novel and synthetic microRNA delivers potent antitumor activities in colorectal tumor models. Invest New Drugs 2021. [PMID: 33909231 DOI: 10.1007/s10637-021-01123-4] [Reference Citation Analysis]
19 Jiang P, Yang F, Zou C, Bao T, Wu M, Yang D, Bu S. The construction and analysis of a ferroptosis-related gene prognostic signature for pancreatic cancer. Aging (Albany NY) 2021;13:10396-414. [PMID: 33819918 DOI: 10.18632/aging.202801] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Purvis IJ, Velpula KK, Guda MR, Nguyen D, Tsung AJ, Asuthkar S. B7-H3 in Medulloblastoma-Derived Exosomes; A Novel Tumorigenic Role. Int J Mol Sci 2020;21:E7050. [PMID: 32992699 DOI: 10.3390/ijms21197050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Feng Y, Xie K, Yin Y, Li B, Pi C, Xu X, Huang T, Zhang J, Wang B, Gu H, Fang J. A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor Activity. Life 2022;12:157. [DOI: 10.3390/life12020157] [Reference Citation Analysis]
22 Liao H, Ding M, Zhou N, Yang Y, Chen L. B7‑H3 promotes the epithelial‑mesenchymal transition of NSCLC by targeting SIRT1 through the PI3K/AKT pathway. Mol Med Rep 2022;25:79. [PMID: 35029291 DOI: 10.3892/mmr.2022.12595] [Reference Citation Analysis]
23 Wang C, Feng H, Cheng X, Liu K, Cai D, Zhao R. Potential Therapeutic Targets of B7 Family in Colorectal Cancer. Front Immunol 2020;11:681. [PMID: 32477326 DOI: 10.3389/fimmu.2020.00681] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]